Showing results (951-960 of 12,111) with videos related to

Sort By:
Pageof 1,212
Neuropharmacology|June 28, 2019
Gut microbiota depletion from early adolescence alters adult immunological and neurobehavioral responses in a mouse model of multiple sclerosisMaryam Zeraati, Mohsen Enayati, Laya Kafami, et al.
Neuropharmacology|May 26, 2019
Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinasesAlessandro Martini, Alberto Cordella, Antonio Pisani, et al.
Neuropharmacology|October 14, 2018
The anticonvulsant lamotrigine enhances Ih in layer 2/3 neocortical pyramidal neurons of patients with pharmacoresistant epilepsyJanna Lehnhoff, Ulf Strauss, Stephan Wierschke, et al.
Neuropharmacology|April 19, 2019
Epigenetic regulation of immediate-early gene Nr4a2/Nurr1 in the medial habenula during reinstatement of cocaine-associated behaviorAlberto J López, Thekla J Hemstedt, Yousheng Jia, et al.
Neuropharmacology|April 23, 2019
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphineChloe J Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology|June 15, 2019
DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signalingShuyi Chen, Mei Zhou, Jie Sun, et al.
Neuropharmacology|August 1, 1985
Comparison of benzodiazepine receptor binding in membranes from human or rat brainW Sieghart, A Eichinger, P Riederer, et al.
Neuropharmacology|August 1, 1985
Specific [3H]neurotensin binding to rat spinal cord membranesJ W Villiger
Neuropharmacology|September 10, 2018
Circulating microRNAs as biomarkers in traumatic brain injuryKathryn Toffolo, Jennifer Osei, William Kelly, et al.
Neuropharmacology|September 10, 2018
Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid systemMarieka V DeVuono, Kelly M Hrelja, Lauren Sabaziotis, et al.
Pageof 1,212